Literature DB >> 8520128

Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory mice.

R Wiger1, J K Hongslo, D P Evenson, P De Angelis, P E Schwarze, J A Holme.   

Abstract

High doses of acetaminophen (400 mg/kg) or hydroxyurea (200 mg/kg) given intraperitoneally daily for 5 d caused reduction in relative testicular weight in mice (B6C3/F1/BOM M). Testicular atrophy of several tubules was seen in the hydroxyurea-treated mice 5 d after the last exposure, whereas acetaminophen did not lead to such changes. Exposure to acetaminophen caused neither a depletion of glutathione in the testis nor a marked increase in covalent binding. In contrast, significant decreases in the incorporation of thymidine into the testis were observed during the first 3 h following a single treatment with acetaminophen (100 to 400 mg/kg) or hydroxyurea (100 to 200 mg/kg). In mice treated with acetaminophen (400 mg/kg) or hydroxyurea (200 mg/kg) daily for 5 d, flow cytometric analysis revealed large reductions in one of the tetraploid populations of testicular cells (mostly early pachytene spermatocytes) on days 5 and 10. Changes in the populations of the various spermatid stages occurred later; thus, both compounds appeared to cause a delay in spermiogenesis. Indications of abnormal chromatin structure were seen in an increased frequency of vas deferens sperm on days 27 and 33 after the last exposure, when measured as increased susceptibility towards DNA denaturation in situ. In conclusion, high doses of acetaminophen or hydroxyurea inhibit DNA synthesis in the testis. The present data indicate that this leads to reduced testicular weight, a reduction in the number of early pachytene spermatocytes, changes in the proportions of the various spermatid stages, and an apparent alteration in sperm chromatin structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520128     DOI: 10.1016/0890-6238(94)00052-x

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  8 in total

1.  Effects of hydroxyurea on CNV induction in the mouse germline.

Authors:  Martin F Arlt; Sountharia Rajendran; Sandra N Holmes; Kathleen Wang; Ingrid L Bergin; Samreen Ahmed; Thomas E Wilson; Thomas W Glover
Journal:  Environ Mol Mutagen       Date:  2018-09-15       Impact factor: 3.216

2.  Inhibitory activity of black mulberry (Morus nigra) extract against testicular, liver and kidney toxicity induced by paracetamol in mice.

Authors:  Kawthar A Diab; Maha A Fahmy; Emad M Hassan; Zeinab M Hassan; Enayat A Omara; Negm S Abdel-Samie
Journal:  Mol Biol Rep       Date:  2020-01-25       Impact factor: 2.316

3.  Hydroxyurea therapy: a rare cause of reversible azoospermia.

Authors:  Junaid Masood; Azhar Hafeez; Andrew Hughes; Jayanta M Barua
Journal:  Int Urol Nephrol       Date:  2007-03-01       Impact factor: 2.370

4.  Association Between Male Use of Pain Medication and Fecundability.

Authors:  Amelia K Wesselink; Kathryn A Bresnick; Elizabeth E Hatch; Kenneth J Rothman; Ellen M Mikkelsen; Tanran R Wang; Krista F Huybrechts; Lauren A Wise
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

5.  Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.

Authors:  Mário Angelo Claudino; Kleber Yotsumoto Fertrin
Journal:  Anemia       Date:  2012-06-13

6.  EDC IMPACT: Reduced sperm counts in rats exposed to human relevant mixtures of endocrine disrupters.

Authors:  M Axelstad; U Hass; M Scholze; S Christiansen; A Kortenkamp; J Boberg
Journal:  Endocr Connect       Date:  2017-12-04       Impact factor: 3.335

7.  Development of a Test Method for the Evaluation of DNA Damage in Mouse Spermatogonial Stem Cells.

Authors:  Hye Lyun Jeon; Jung-Sun Yi; Tae Sung Kim; Youkyung Oh; Hye Jeong Lee; Minseong Lee; Jin Seok Bang; Kinarm Ko; Il Young Ahn; Kyungyuk Ko; Joohwan Kim; Hye-Kyung Park; Jong Kwon Lee; Soo Jung Sohn
Journal:  Toxicol Res       Date:  2017-04-15

8.  Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.

Authors:  Kea M Jones; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Maria P Aguinaga; Edward R Hills; Valerie Montgomery Rice; Phillip Bourne; Donald Bruce; Anthony E Archibong
Journal:  Int J Environ Res Public Health       Date:  2009-03-16       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.